Rare diseases
Investigational molecules
Locations
Plesmanlaan 125, 1066 CX Amsterdam, The Netherlands
Research activity is centered on congenital atransferrinaemia and hypotransferrinaemia, with attention to conditions marked by severe disruption of transferrin availability and iron transport.
The sponsor’s clinical focus includes treatment areas where restoring apotransferrin function is relevant to managing profound anemia and related systemic effects.
Prothya Biosolutions Netherlands B.V. runs clinical trials in conditions such as Congenital hypotransferrinaemia, Hypochromic anaemia, Hypotransferrinaemia, Iron overload, among others.
Clinical trials run by this sponsor – those enrolling participants first.
GermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
